Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Santiago Olaechea

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
JCSM Clinical Reports|June 20, 2022
The influence of tumour fluorodeoxyglucose avidity and cachexia development on patient survival in oesophageal or gastroesophageal junction cancerSantiago Olaechea, Bhavani S Gannavarapu, Anne Gilmore, et al.
Frontiers in Oncology|June 24, 2022
Associations of Prior Chronic Use of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) and Glucocorticoids With Cachexia Incidence and SurvivalSantiago Olaechea, Anne Gilmore, Christian Alvarez, et al.
JCO Oncology Practice|April 26, 2023
Race, Ethnicity, and Socioeconomic Factors as Determinants of Cachexia Incidence and Outcomes in a Retrospective Cohort of Patients With Gastrointestinal Tract CancerSantiago Olaechea, Brandon Sarver, Alison Liu, et al.
JTO Clinical and Research Reports|April 25, 2023
Racial, Ethnic, and Socioeconomic Characteristics Independently Predict for Cachexia Risk and Associated Survival Outcomes in Stage IV NSCLC: A Brief ReportSantiago Olaechea, Alison Liu, Brandon Sarver, et al.
Frontiers in Oncology|July 11, 2022
Primary Tumor Fluorine-18 Fluorodeoxydglucose (<sup>18</sup>F-FDG) Is Associated With Cancer-Associated Weight Loss in Non-Small Cell Lung Cancer (NSCLC) and Portends Worse SurvivalSantiago Olaechea, Bhavani S Gannavarapu, Christian Alvarez, et al.
Journal of Cachexia, Sarcopenia and Muscle|September 27, 2022
A preponderance of gastrointestinal cancer patients transition into cachexia syndromeLinda Anne Gilmore, Santiago Olaechea, Brian W Gilmore, et al.
Journal of Cachexia, Sarcopenia and Muscle|April 8, 2026
Undetected Weight Loss Associates With Upstaging in Cancer PatientsL Anne Gilmore, Evie Y Dunsky, A Jacob Miller, et al.
American Journal of Clinical Oncology|November 27, 2023
Impact of Pretreatment Weight Loss on Radiotherapy Utilization and Clinical Outcomes in Non-Small Cell Lung CancerChristian M Alvarez, Maureen Aliru, Bhavani S Gannavarapu, et al.
American Journal of Clinical Oncology|May 5, 2025
Prevalence and Development of Cachexia Before and After Diagnosis of Non-small Cell Lung CancerL Anne Gilmore, Jonas Willmann, Santiago Olaechea, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
JCSM Clinical Reports|June 20, 2022
The influence of tumour fluorodeoxyglucose avidity and cachexia development on patient survival in oesophageal or gastroesophageal junction cancerSantiago Olaechea, Bhavani S Gannavarapu, Anne Gilmore, et al.
Frontiers in Oncology|June 24, 2022
Associations of Prior Chronic Use of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) and Glucocorticoids With Cachexia Incidence and SurvivalSantiago Olaechea, Anne Gilmore, Christian Alvarez, et al.
JCO Oncology Practice|April 26, 2023
Race, Ethnicity, and Socioeconomic Factors as Determinants of Cachexia Incidence and Outcomes in a Retrospective Cohort of Patients With Gastrointestinal Tract CancerSantiago Olaechea, Brandon Sarver, Alison Liu, et al.
JTO Clinical and Research Reports|April 25, 2023
Racial, Ethnic, and Socioeconomic Characteristics Independently Predict for Cachexia Risk and Associated Survival Outcomes in Stage IV NSCLC: A Brief ReportSantiago Olaechea, Alison Liu, Brandon Sarver, et al.
Frontiers in Oncology|July 11, 2022
Primary Tumor Fluorine-18 Fluorodeoxydglucose (<sup>18</sup>F-FDG) Is Associated With Cancer-Associated Weight Loss in Non-Small Cell Lung Cancer (NSCLC) and Portends Worse SurvivalSantiago Olaechea, Bhavani S Gannavarapu, Christian Alvarez, et al.
Journal of Cachexia, Sarcopenia and Muscle|September 27, 2022
A preponderance of gastrointestinal cancer patients transition into cachexia syndromeLinda Anne Gilmore, Santiago Olaechea, Brian W Gilmore, et al.
Journal of Cachexia, Sarcopenia and Muscle|April 8, 2026
Undetected Weight Loss Associates With Upstaging in Cancer PatientsL Anne Gilmore, Evie Y Dunsky, A Jacob Miller, et al.
American Journal of Clinical Oncology|November 27, 2023
Impact of Pretreatment Weight Loss on Radiotherapy Utilization and Clinical Outcomes in Non-Small Cell Lung CancerChristian M Alvarez, Maureen Aliru, Bhavani S Gannavarapu, et al.
American Journal of Clinical Oncology|May 5, 2025
Prevalence and Development of Cachexia Before and After Diagnosis of Non-small Cell Lung CancerL Anne Gilmore, Jonas Willmann, Santiago Olaechea, et al.
Pageof 1